Peter Hur is a dedicated Health Economics and Outcomes Research professional currently serving as the Director of Worldwide HEOR Oncology at Pfizer. With a strong background in developing HEOR strategies, Peter has led significant research initiatives across various companies, including Bristol-Myers Squibb and Novartis, contributing to the optimization of product market access and value proposition. Peter holds a PharmD from the University of North Carolina Eshelman School of Pharmacy and an MBA from the University of North Carolina at Chapel Hill, complemented by a Bachelor's degree in Mechanical Engineering from the University of Michigan. Currently, Peter is pursuing a Master's degree in Applied Data Science at the University of Michigan.
This person is not in the org chart
This person is not in any teams
This person is not in any offices